Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Cannabis Terpenes Activate A2A Receptors in Neuropathic Pain
2026-08-26
Schwarz et al. show that several Cannabis sativa terpenes reduce pain-related behavior in mouse models of chemotherapy-induced neuropathy and inflammatory pain through an adenosine A2A receptor-dependent mechanism. The combination of behavioral pharmacology, spinal CRISPR knockdown, cAMP and binding assays, and molecular modeling provides a mechanistic framework for evaluating non-cannabinoid terpene analgesia.
-
NPT1-Mediated PAH Transport and Faropenem
2026-08-26
The reference study provided the first molecular evidence that human renal NPT1 can transport p-aminohippuric acid (PAH) across the apical membrane of proximal-tubule cells. Its chloride sensitivity, substrate inhibition profile, and recognition of faropenem connect phosphate-transporter biology with renal handling of organic anions, while also defining important limits for interpreting antibiotic experiments.
-
Peptidisc-Assisted Multimeric Nanobody Engineering
2026-08-25
Chen and Duong van Hoa describe a peptidisc-assisted hydrophobic clustering strategy that converts engineered nanobodies into soluble multimeric, bispecific, and autofluorescent assemblies. The preprint links multivalency to stronger functional binding and suggests a modular alternative to tandem fusion, self-assembly domains, and chemical cross-linking.
-
Sulfo-NHS-SS-Biotin: Cell-Surface Workflows
2026-08-24
Build reversible protein-labeling workflows for surface proteomics, affinity capture, and validation of cell-surface interactions. The kit combines water-compatible NHS-ester chemistry with disulfide cleavage, enabling selective labeling, enrichment, and controlled release from streptavidin.
-
Vorinostat: HDAC Inhibition and Apoptosis
2026-08-24
Vorinostat, also called suberoylanilide hydroxamic acid or SAHA, is a small-molecule histone deacetylase inhibitor used in cancer biology research. Its reported HDAC potency, cell-growth effects, formulation limits, and relationship to emerging RNA Pol II apoptosis biology require assay-specific interpretation.
-
AMD-070 Hydrochloride: CXCR4 Research Workflows
2026-08-23
Build reproducible CXCR4 migration, immune-cell, and translational assays with AMD-070 hydrochloride, while separating practical screening conditions from clinical evidence. The workflow also clarifies when WHIM and Waldenström macroglobulinemia models can inform antiviral hypotheses without overstating maturity.
-
Cy7 NHS Ester: Practical Labeling and QC
2026-08-22
Cy7 NHS ester provides a water-compatible route for attaching a near-infrared fluorophore to accessible amino groups on proteins, peptides, and related biomolecules. It is useful for aqueous labeling and imaging workflows, but it should not be selected for long-term storage of prepared dye solutions, strictly non-aqueous reactions, or applications requiring unvalidated in vivo performance.
-
Sulfo-Cy3 NHS Ester for Reliable Cell Assays
2026-08-21
Learn how Sulfo-Cy3 NHS ester, SKU A8107, can support reproducible protein labeling, uptake studies, and fluorescence controls around cell viability and vascular biology assays. This scenario-based guide separates biomolecule tracing from viability readouts and translates product specifications into practical laboratory decisions.
-
Tetraethylammonium Chloride: Assay Logic
2026-08-20
Tetraethylammonium chloride is more than a potassium-channel blocker: it is a mechanistic perturbation tool for separating pore conductance from downstream physiology. This guide translates ion-flux, patch-clamp, vascular, and secretory evidence into better assay controls and interpretation.
-
ABT-888 (Veliparib): Reliable Assay Workflows
2026-08-20
This scenario-driven guide explains how ABT-888 (Veliparib), SKU A3002, can support reproducible PARP-inhibition studies in viability, cytotoxicity, and combination assays. It connects solvent handling, experimental design, and context-specific interpretation with product data and recent DNA-damage-response findings.
-
Ferroptosis–Apoptosis Interplay and BH3-Mimetics
2026-08-19
The 2025 Cell Death & Differentiation study shows that ferroptosis and apoptosis can overlap rather than behave as fully independent death programs. It further demonstrates that BH3-mimetics may enhance, redirect, or unexpectedly suppress ferroptotic death, depending on cellular context and compound-associated antioxidant activity.
-
(+)-Bicuculline: Practical Workflow Guide
2026-08-19
(+)-Bicuculline is a neuroscience research tool for competitive GABAA receptor antagonism and investigation of inhibitory synaptic transmission. This guide focuses on solvent handling, stock preparation, controls, and interpretation boundaries; the compound is for scientific research only and not for diagnostic, therapeutic, or medical use.
-
Cy7 NHS Ester: Practical Labeling and QC Guide
2026-08-18
Cy7 NHS ester is a water-soluble near-infrared dye for bioimaging that enables labeling of accessible amino groups on proteins and peptides. It is suited to aqueous labeling of sensitive biomolecules, but not to targets lacking primary amines or workflows that require long-term storage of prepared dye solutions.
-
Risedronate Sodium: From Bone to Lung Research
2026-08-18
Risedronate Sodium combines a validated FPPS-inhibition mechanism for bone metabolism research with a preclinical inhalation strategy that targets alveolar macrophages. This guide translates those findings into practical cell, formulation, aerosol, and animal-model workflows while emphasizing solubility, deposition, and assay controls.
-
AIBP-LRP2 Control of CXCR4+ Collateral Growth
2026-08-17
Zhu et al. identify an AIBP-LRP2-HDL-miR-223 pathway that suppresses CXCR4+ stemlike capillary endothelial cells and limits collateral circulation after ischemia. The study proposes a two-phase model in which CXCR4+ endothelial cells first expand and subsequently acquire arterial characteristics, offering a mechanistic framework for revascularization research in peripheral artery disease.